{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:27:49Z","timestamp":1790227669173,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T00:00:00Z","timestamp":1343692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11910-012-0302-7","type":"journal-article","created":{"date-parts":[[2012,7,30]],"date-time":"2012-07-30T06:00:31Z","timestamp":1343628031000},"page":"528-536","source":"Crossref","is-referenced-by-count":76,"title":["Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia"],"prefix":"10.1007","volume":"12","author":[{"given":"Masood","family":"Manoochehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,31]]},"reference":[{"key":"302_CR1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546\u201354.","journal-title":"Neurology"},{"key":"302_CR2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/WAD.0b013e31815c3445","volume":"21","author":"K Rascovsky","year":"2007","unstructured":"Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007;21:S14\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"302_CR3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archneur.64.6.830","volume":"64","author":"MF Mendez","year":"2007","unstructured":"Mendez MF, Shapira JS, McMurtray A, et al. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol. 2007;64:830\u20135.","journal-title":"Arch Neurol"},{"key":"302_CR4","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"\u2022\u2022 Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377. This paper presents new criteria for diagnosing bvFTD. The paper demonstrates that the criteria are more sensitive and presents data on the relative prevalance on behavioral symptoms in pathologically confirmed cases.","journal-title":"Brain"},{"key":"302_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000080123","volume":"18","author":"JC Mourik","year":"2004","unstructured":"Mourik JC, Rosso SM, Niermeijer MF, et al. Frontotemporal dementia: behavioral symptoms and caregiver distress. Dement Geriatr Cogn Disord. 2004;18:299\u2013306.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"302_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropsychologia.2009.08.001","volume":"48","author":"M Adenzato","year":"2010","unstructured":"Adenzato M, Cavallo M, Enrici I. Theory of mind ability in the behavioural variant of frontotemporal dementia: an analysis of the neural, cognitive, and social levels. Neuropsychologia. 2010;48:2\u201312.","journal-title":"Neuropsychologia"},{"key":"302_CR7","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/brain\/awl254","volume":"129","author":"KP Rankin","year":"2006","unstructured":"Rankin KP, Gorno-Tempini ML, Allison SC, et al. Structural anatomy of empathy in neurodegenerative disease. Brain. 2006;129:2945\u201356.","journal-title":"Brain"},{"key":"302_CR8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1517\/14728222.12.11.1367","volume":"12","author":"ED Huey","year":"2008","unstructured":"Huey ED, Armstrong N, Momeni P, Grafman J. Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia. Expert Opin Ther Targets. 2008;12:1367\u201376.","journal-title":"Expert Opin Ther Targets"},{"key":"302_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.73.4.371","volume":"73","author":"M Ikeda","year":"2002","unstructured":"Ikeda M, Brown J, Holland AJ, et al. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;73:371\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"302_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/jnnp.62.3.293-a","volume":"62","author":"MF Mendez","year":"1997","unstructured":"Mendez MF, Foti DJ. Lethal hyperoral behaviour from the Kluver-Bucy syndrome. J Neurol Neurosurg Psychiatry. 1997;62:293\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"302_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12031-011-9547-x","volume":"45","author":"O Piguet","year":"2011","unstructured":"Piguet O. Eating disturbance in behavioural-variant frontotemporal dementia. J Mol Neurosci. 2011;45:589\u201393.","journal-title":"J Mol Neurosci"},{"key":"302_CR12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.22244","volume":"69","author":"O Piguet","year":"2011","unstructured":"Piguet O, Petersen A, Yin Ka Lam B, et al. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol. 2011;69:312\u20139.","journal-title":"Ann Neurol"},{"key":"302_CR13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropsychologia.2007.11.001","volume":"46","author":"CL Carey","year":"2008","unstructured":"Carey CL, Woods SP, Damon J, et al. Discriminant validity and neuroanatomical correlates of rule monitoring in frontotemporal dementia and Alzheimer's disease. Neuropsychologia. 2008;46:1081\u20137.","journal-title":"Neuropsychologia"},{"key":"302_CR14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jocn.2009.03.005","volume":"16","author":"P Lillo","year":"2009","unstructured":"Lillo P, Hodges JR. Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci. 2009;16:1131\u20135.","journal-title":"J Clin Neurosci"},{"key":"302_CR15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archneur.1996.00550070129021","volume":"53","author":"ML Levy","year":"1996","unstructured":"Levy ML, Miller BL, Cummings JL, et al. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol. 1996;53:687\u201390.","journal-title":"Arch Neurol"},{"key":"302_CR16","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48:S10\u20136.","journal-title":"Neurology"},{"key":"302_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2005.04.014","volume":"236","author":"S Srikanth","year":"2005","unstructured":"Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 2005;236:43\u20138.","journal-title":"J Neurol Sci"},{"key":"302_CR18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jnnp.69.2.178","volume":"69","author":"S Bozeat","year":"2000","unstructured":"Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000;69:178\u201386.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"302_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archneur.64.4.535","volume":"64","author":"RM Liscic","year":"2007","unstructured":"Liscic RM, Storandt M, Cairns NJ, Morris JC. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. Arch Neurol. 2007;64:535\u201340.","journal-title":"Arch Neurol"},{"key":"302_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/13803390903427414","volume":"32","author":"JL Mathias","year":"2010","unstructured":"\u2022 Mathias JL, Morphett K. Neurobehavioral differences between Alzheimer's disease and frontotemporal dementia: a meta-analysis. J Clin Exp Neuropsychol. 2010;32:682\u201398. This paper reviews studies over a 14-year period that included AD and FTD neurobehavioral measures. The paper finds that FTD-specific scales are best at discriminating between AD and FTD.","journal-title":"J Clin Exp Neuropsychol"},{"key":"302_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1017\/S1355617700644041","volume":"6","author":"A Kertesz","year":"2000","unstructured":"Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000;6:460\u20138.","journal-title":"J Int Neuropsychol Soc"},{"key":"302_CR22","first-page":"185","volume":"17","author":"CA Marczinski","year":"2004","unstructured":"Marczinski CA, Davidson W, Kertesz A. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol. 2004;17:185\u201390.","journal-title":"Cogn Behav Neurol"},{"key":"302_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/gps.1249","volume":"20","author":"PP Deyn De","year":"2005","unstructured":"De Deyn PP, Engelborghs S, Saerens J, et al. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease. Int J Geriatr Psychiatry. 2005;20:70\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"302_CR24","unstructured":"Grace, J.a.M., P.F., Frontal Systems Behavioral Scale: Professional Manual. 2001, Lutz, FL: Psychological Assessment Resources, Inc."},{"key":"302_CR25","unstructured":"National Alzheimer's Coordinating Center. Available at www.alz.washington.edu . Accessed May 2012."},{"key":"302_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1017\/S0317167100054147","volume":"38","author":"TW Chow","year":"2011","unstructured":"Chow TW, Pio FJ, Rockwood K. An international needs assessment of caregivers for frontotemporal dementia. Can J Neurol Sci. 2011;38:753\u20137.","journal-title":"Can J Neurol Sci"},{"key":"302_CR27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4088\/JCP.10m06382oli","volume":"72","author":"JD Woolley","year":"2011","unstructured":"Woolley JD, Khan BK, Murthy NK, et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72:126\u201333.","journal-title":"J Clin Psychiatry"},{"key":"302_CR28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jnnp.2007.122853","volume":"79","author":"E Salmon","year":"2008","unstructured":"Salmon E, Perani D, Collette F, et al. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2008;79:176\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"302_CR29","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1523\/JNEUROSCI.2324-08.2008","volume":"28","author":"M Koenigs","year":"2008","unstructured":"Koenigs M, Huey ED, Calamia M, et al. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J Neurosci. 2008;28:12341\u20138.","journal-title":"J Neurosci"},{"key":"302_CR30","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","volume":"58","author":"GM McKhann","year":"2001","unstructured":"McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001;58:1803\u20139.","journal-title":"Arch Neurol"},{"key":"302_CR31","first-page":"154","volume":"9","author":"OL Lopez","year":"1996","unstructured":"Lopez OL, Gonzalez MP, Becker JT, Reynolds CF, et al. Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia. Neuropsychiatry Neuropsychol Behav Neurol. 1996;9:154\u201361.","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"302_CR32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","volume":"135","author":"JS Snowden","year":"2012","unstructured":"Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135:693\u2013708.","journal-title":"Brain"},{"key":"302_CR33","first-page":"637","volume":"3","author":"PK Panegyres","year":"2007","unstructured":"Panegyres PK, Graves A, Frencham KA. The clinical differentiation of fronto-temporal dementia from psychiatric disease. Neuropsychiatr Dis Treat. 2007;3:637\u201345.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"302_CR34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4088\/JCP.v69n0109","volume":"69","author":"KP Rankin","year":"2008","unstructured":"Rankin KP, Santos-Modesitt W, Kramer JH, et al. Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias. J Clin Psychiatry. 2008;69:60\u201373.","journal-title":"J Clin Psychiatry"},{"key":"302_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1533317509356692","volume":"25","author":"H Bei","year":"2010","unstructured":"\u2022 Bei H, Ross L, Neuhaus J, et al. Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2010;25:128\u201333. This paper uses a large data set to determine the prevalence of medications used to treat bvFTD.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"302_CR36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000093102","volume":"22","author":"ME Vugt de","year":"2006","unstructured":"de Vugt ME, Riedijk SR, Aalten P, et al. Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;22:35\u201341.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"302_CR37","doi-asserted-by":"crossref","unstructured":"Lopez-Pousa S, Calvo-Perxas L, Lejarreta S, et al. Use of antidementia drugs in frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen, 2012.","DOI":"10.1177\/1533317512447887"},{"key":"302_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000191304.55196.4d","volume":"66","author":"ED Huey","year":"2006","unstructured":"Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66:17\u201322.","journal-title":"Neurology"},{"key":"302_CR39","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00002512-200421140-00003","volume":"21","author":"R Moretti","year":"2004","unstructured":"Moretti R, Torre P, Antonello RM, et al. Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging. 2004;21:931\u20137.","journal-title":"Drugs Aging"},{"key":"302_CR40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","volume":"15","author":"MF Mendez","year":"2007","unstructured":"Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15:84\u20137.","journal-title":"Am J Geriatr Psychiatry"},{"key":"302_CR41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000113034","volume":"25","author":"A Kertesz","year":"2008","unstructured":"Kertesz A, Morlog D, Light M, et al. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord. 2008;25:178\u201385.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"302_CR42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1586\/ern.11.6","volume":"11","author":"GA Kerchner","year":"2011","unstructured":"Kerchner GA, Tartaglia MC, Boxer A. Abhorring the vacuum: use of Alzheimer's disease medications in frontotemporal dementia. Expert Rev Neurother. 2011;11:709\u201317.","journal-title":"Expert Rev Neurother"},{"key":"302_CR43","doi-asserted-by":"crossref","unstructured":"Areosa SA, Sherriff F, McShane R. Memantine for dementia. Cochrane Database Syst Rev, 2005: CD003154.","DOI":"10.1002\/14651858.CD003154.pub3"},{"key":"302_CR44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/WAD.0b013e318047df5d","volume":"21","author":"MM Swanberg","year":"2007","unstructured":"Swanberg MM. Memantine for behavioral disturbances in frontotemporal dementia: a case series. Alzheimer Dis Assoc Disord. 2007;21:164\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"302_CR45","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gps.1973","volume":"23","author":"J Diehl-Schmid","year":"2008","unstructured":"Diehl-Schmid J, Forstl H, Perneczky R, et al. A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry. 2008;23:754\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"302_CR46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/WAD.0b013e318197852f","volume":"23","author":"AL Boxer","year":"2009","unstructured":"Boxer AL, Lipton AM, Womack K, et al. An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord. 2009;23:211\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"302_CR47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3233\/JAD-2010-101632","volume":"23","author":"M Vercelletto","year":"2011","unstructured":"Vercelletto M, Boutoleau-Bretonniere C, Volteau C, et al. Memantine in behavioral variant frontotemporal dementia: negative results. J Alzheimers Dis. 2011;23:749\u201359.","journal-title":"J Alzheimers Dis"},{"key":"302_CR48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2147\/NDT.S22635","volume":"7","author":"TW Chow","year":"2011","unstructured":"Chow TW, Graff-Guerrero A, Verhoeff NP, et al. Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatr Dis Treat. 2011;7:415\u201324.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"302_CR49","unstructured":"ClinicalTrials.gov: Memantine (10\u00a0mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia. Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00545974 . Accessed May 2012"},{"key":"302_CR50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-4580(98)00086-4","volume":"19","author":"M Sjogren","year":"1998","unstructured":"Sjogren M, Minthon L, Passant U, et al. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging. 1998;19:379\u201384.","journal-title":"Neurobiol Aging"},{"key":"302_CR51","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.58.10.1489","volume":"58","author":"JO Rinne","year":"2002","unstructured":"Rinne JO, Laine M, Kaasinen V, et al. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology. 2002;58:1489\u201393.","journal-title":"Neurology"},{"key":"302_CR52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00213-003-1686-5","volume":"172","author":"JB Deakin","year":"2004","unstructured":"Deakin JB, Rahman S, Nestor PJ, et al. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl). 2004;172:400\u20138.","journal-title":"Psychopharmacology (Berl)"},{"key":"302_CR53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000067021","volume":"49","author":"R Moretti","year":"2003","unstructured":"Moretti R, Torre P, Antonello RM, et al. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol. 2003;49:13\u20139.","journal-title":"Eur Neurol"},{"key":"302_CR54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4088\/JCP.v58n0506","volume":"58","author":"JR Swartz","year":"1997","unstructured":"Swartz JR, Miller BL, Lesser IM, Darby AL. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry. 1997;58:212\u20136.","journal-title":"J Clin Psychiatry"},{"key":"302_CR55","unstructured":"Herrmann N, Black SE, Chow T, et al. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiatry, 2011."},{"key":"302_CR56","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/mds.20465","volume":"20","author":"MF Mendez","year":"2005","unstructured":"Mendez MF, Shapira JS, Miller BL. Stereotypical movements and frontotemporal dementia. Mov Disord. 2005;20:742\u20135.","journal-title":"Mov Disord"},{"key":"302_CR57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000076343","volume":"17","author":"M Ikeda","year":"2004","unstructured":"Ikeda M, Shigenobu K, Fukuhara R, et al. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord. 2004;17:117\u201321.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"302_CR58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000077171","volume":"17","author":"F Lebert","year":"2004","unstructured":"Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord. 2004;17:355\u20139.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"302_CR59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0269881110387547","volume":"25","author":"JT O'Brien","year":"2011","unstructured":"O'Brien JT, Burns A, B.A.P.D.C. Group. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2011;25:997\u20131019.","journal-title":"J Psychopharmacol"},{"key":"302_CR60","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","volume":"306","author":"AR Maher","year":"2011","unstructured":"Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306:1359\u201369.","journal-title":"JAMA"},{"key":"302_CR61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00004714-200006000-00018","volume":"20","author":"RC Curtis","year":"2000","unstructured":"Curtis RC, Resch DS. Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. J Clin Psychopharmacol. 2000;20:384\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"302_CR62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15622970601016538","volume":"8","author":"A Fellgiebel","year":"2007","unstructured":"Fellgiebel A, Muller MJ, Hiemke C, et al. Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry. 2007;8:123\u20136.","journal-title":"World J Biol Psychiatry"},{"key":"302_CR63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/153331750301800410","volume":"18","author":"R Moretti","year":"2003","unstructured":"Moretti R, Torre P, Antonello RM, et al. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients. Am J Alzheimers Dis Other Demen. 2003;18:205\u201314.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"302_CR64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1176\/appi.neuropsych.13.3.347","volume":"13","author":"MF Mendez","year":"2001","unstructured":"Mendez MF, Lipton A. Emergent neuroleptic hypersensitivity as a herald of presenile dementia. J Neuropsychiatry Clin Neurosci. 2001;13:347\u201356.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"302_CR65","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000197896","volume":"24","author":"MF Mendez","year":"2009","unstructured":"Mendez MF. Frontotemporal dementia: therapeutic interventions. Front Neurol Neurosci. 2009;24:168\u201378.","journal-title":"Front Neurol Neurosci"},{"key":"302_CR66","first-page":"179","volume":"97","author":"M Ikeda","year":"1995","unstructured":"Ikeda M, Tanabe H, Horino T, et al. Care for patients with Pick's disease\u2013by using their preserved procedural memory. Seishin Shinkeigaku Zasshi. 1995;97:179\u201392.","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"302_CR67","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/WAD.0b013e31815bf774","volume":"21","author":"J Merrilees","year":"2007","unstructured":"Merrilees J. A model for management of behavioral symptoms in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord. 2007;21:S64\u20139.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"302_CR68","doi-asserted-by":"crossref","unstructured":"Mioshi E, Foxe D, Leslie F, et al. The impact of dementia severity on caregiver burden in frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord, 2012.","DOI":"10.1097\/WAD.0b013e318247a0bc"},{"key":"302_CR69","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awn234","volume":"131","author":"DS Knopman","year":"2008","unstructured":"Knopman DS, Kramer JH, Boeve BF, et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain. 2008;131:2957\u201368.","journal-title":"Brain"},{"key":"302_CR70","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.npp.1300886","volume":"31","author":"S Rahman","year":"2006","unstructured":"Rahman S, Robbins TW, Hodges JR, et al. Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology. 2006;31:651\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"302_CR71","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.0b013e3182574fa1","volume":"78","author":"ED Gennatas","year":"2012","unstructured":"Gennatas ED, Cholfin JA, Zhou J, et al. COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures. Neurology. 2012;78:1663\u20139.","journal-title":"Neurology"},{"key":"302_CR72","unstructured":"ClinicalTrials.gov: Effects of Tolcapone on Frontotemporal Dementia. Available at www.clinicaltrials.gov\/ct2\/show\/NCT00604591 . Accessed May 2012."},{"key":"302_CR73","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12031-011-9550-2","volume":"45","author":"EC Finger","year":"2011","unstructured":"Finger EC. New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition. J Mol Neurosci. 2011;45:696\u2013701.","journal-title":"J Mol Neurosci"},{"key":"302_CR74","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awr171","volume":"134","author":"S Jesso","year":"2011","unstructured":"Jesso S, Morlog D, Ross S, et al. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain. 2011;134:2493\u2013501.","journal-title":"Brain"},{"key":"302_CR75","unstructured":"ClinicalTrials.gov: Safety Study of Intranasal Oxytocin in Frontotemporal Dementia. Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01386333 . Accessed May 2012."},{"key":"302_CR76","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archpsyc.55.8.708","volume":"55","author":"EF Coccaro","year":"1998","unstructured":"Coccaro EF, Kavoussi RJ, Hauger RL, et al. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry. 1998;55:708\u201314.","journal-title":"Arch Gen Psychiatry"},{"key":"302_CR77","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/humu.9510","volume":"28","author":"ZM Prichard","year":"2007","unstructured":"Prichard ZM, Mackinnon AJ, Jorm AF, Easteal S. AVPR1A and OXTR polymorphisms are associated with sexual and reproductive behavioral phenotypes in humans. Mutation in brief no. 981. Online. Hum Mutat. 2007;28:1150.","journal-title":"Hum Mutat"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0302-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-012-0302-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0302-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T04:30:47Z","timestamp":1562041847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-012-0302-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,31]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1007\/s11910-012-0302-7","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,31]]}}}